Citation Impact
Citing Papers
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
2014
Cloning of a human parvovirus by molecular screening of respiratory tract samples
2005 Standout
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study
2003
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Testicular Germ-Cell Cancer
1997 Standout
Parvovirus B19 infection infrequently involved in children and adults with myelodysplastic syndrome
1996
Antibodies to parvovirus B19 NS-1 protein in infected individuals
1995
A regional experience of red cell aplasia
1993
Heating the patient: a promising approach?
2002 Standout
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia
2012
The cellular and molecular basis of hyperthermia
2002 Standout
Parvovirus B19 causing leucopenia and neutropenia in a healthy adult
2000
2 B19 parvovirus
1995
Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy
2003
Parvovirus B19 infection and autoimmune disease
2003
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Apoptosis in cancer: from pathogenesis to treatment
2011 Standout
Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity?
2011 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: Design and synthesis as anticancer agents
2012
Molecular, cellular and clinical aspects of Parvovirus B19 infection
1994
Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood
2003
Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: New anticancer agents
2012
A Decade of Progress in Lymphoma: Advances and Continuing Challenges
2010
Antibodies to the Nonstructural Protein of Parvovirus B19 in Persistently Infected Patients: Implications for Pathogenesis
1995
Parvovirus B19
2004 Standout
Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
2009
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
The Tumor Lysis Syndrome
2011 Standout
Human Parvovirus B19
2002 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Novel agents for the treatment of chronic lymphocytic leukemia.
2010
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions
1993
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins
1999
Hyperthermia for the treatment of patients with malignant germ cell tumors
1998
The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability
2001
Lymphoproliferative responses after infection with human parvovirus B19
1996
Parellel inhibition of LH-RH-induced cyclic AMP accumulation and LH and FSH release by LH-RH antagonists in vitro.
1975 StandoutNobel
Works of Gerhard Postner being referenced
Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial.
1996
Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection
1992
Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia
2009
Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study.
2008